🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
587 medicines starting with “L”
MedicineActive substanceLicence holderStatus
Levetiracetam Clonmel 500 mg film-coated tablets
PA0126/326/002
Levetiracetam Clonmel Healthcare Ltd Marketed
Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion
EU/1/13/889/001-002
Levetiracetam Pfizer Europe MA EEIG
Levetiracetam Kabi 10 mg/ml solution for infusion
PA2059/088/002
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam Kabi 5 mg/ml solution for infusion
PA2059/088/001
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam ratiopharm 100 mg/ml oral solution
EU/1/11/702/001-003
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 1000 mg film-coated tablets
EU/1/11/702/025-031
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 250 mg film-coated tablets
EU/1/11/702/004-009
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 500 mg film-coated tablets
EU/1/11/702/010-017
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 750 mg film-coated tablets
EU/1/11/702/018-024
Levetiracetam Ratiopharm GmbH
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
EU/1/11/741/001
Levetiracetam Sun Phamaceutical Industries Europe B.V.
Levetiracetam Teva 1000 mg film-coated tablets
EU/1/11/701/022-028
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 250 mg film-coated tablets
EU/1/11/701/001-004
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 500 mg film-coated tablets
EU/1/11/701/008-014
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 750 mg film-coated tablets
EU/1/11/701/015-021
Levetiracetam Teva Pharma B.V.
Levetiracetam Thame 100 mg/ml oral solution
PA22697/012/001
Levetiracetam Syri Pharma Limited t/a Thame Laboratories Marketed
LEVITRA
EU/1/03/248/1-12
Vardenafil Bayer AG
Levitra 10 mg orodispersible tablets
EU/1/03/248/013-15
VARDENAFIL HYDROCHLORIDE TRIHYDRATE Bayer Schering Pharma AG
Levobupivacaine 0.625 mg/ml solution for infusion
PA2059/009/001
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 1.25 mg/mL solution for infusion
PA2059/009/002
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 2.5 mg/mL solution for injection/infusion
PA2059/009/003
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 5.0 mg/mL solution for injection/infusion
PA2059/009/004
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levobupivacaine 7.5 mg/mL solution for injection/infusion
PA2059/009/005
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
Levocetirizine dihydrochloride 5 mg Film-Coated Tablets
PA22749/003/001
Levocetirizine dihydrochloride Brillpharma (Ireland) Limited Marketed
Levocetirizine Glenmark 5 mg Film-coated Tablets
PA22645/003/001
Levocetirizine dihydrochloride Glenmark Arzneimittel GmbH Not marketed
Levocetirizine Krka 5mg film-coated tablets
PA1347/043/001
Levocetirizine dihydrochloride KRKA, d.d., Novo mesto Marketed
Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets
EU/1/11/706/012-017
Levodopa, Entacapone, Carbidopa monohydrate Orion Corporation
Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets
EU/1/11/706/018-022
Levodopa, Entacapone, Carbidopa monohydrate Orion Corporation
Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets
EU/1/11/706/023-028
Levodopa, Carbidopa monohydrate, Entacapone Orion Corporation
Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets
EU/1/11/706/034-38
Entacapone, Carbidopa monohydrate, Levodopa Orion Corporation
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets
EU/1/11/706/029-033
Entacapone, Levodopa, Carbidopa monohydrate Orion Corporation
Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg film-coated tablets
EU/1/11/706/007-011
Levodopa, Carbidopa monohydrate, Entacapone Orion Corporation
Levofloxacin 5 mg/ml solution for infusion
PA1122/013/001
Levofloxacin Noridem Enterprises Limited Marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/001
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion
PA1217/008/002
Levofloxacin Hikma Farmacêutica (Portugal) S.A. Not marketed
Levofloxacin 5 mg/ml solution for infusion, freeflex bags
PA2059/010/002
Levofloxacin Fresenius Kabi Deutschland GmbH Not marketed
Levofloxacin 5 mg/ml solution for infusion, LDPE bottles
PA2059/010/001
Levofloxacin Fresenius Kabi Deutschland GmbH Marketed
Levofloxacin Krka 250 mg film-coated tablets
PA1347/048/001
Levofloxacin KRKA, d.d., Novo mesto Marketed
Levofloxacin Krka 500 mg film-coated tablets
PA1347/048/002
Levofloxacin KRKA, d.d., Novo mesto Marketed
Levonorgestrel Rowex 1.5mg Tablet
PA0711/267/001
Levonorgestrel Rowex Limited, Marketed
Levosert 52 mg intrauterine delivery system
PA1330/022/001
Levonorgestrel Gedeon Richter Plc Not marketed
Levosert SHI 52 mg Intrauterine Delivery System
PA1330/022/002
Levonorgestrel Gedeon Richter Plc Not marketed
Levosimendan 2.5 mg/ml concentrate for solution for infusion
PA2165/015/001
Levosimendan AS Kalceks Marketed
Levothyroxine 100 micrograms per 5 ml oral solution
PA1142/029/004
Levothyroxine sodium Amdipharm Limited Not marketed
Levothyroxine 25 micrograms per 5 ml oral solution
PA1142/029/002
Levothyroxine sodium Amdipharm Limited Not marketed
Levothyroxine 50 micrograms per 5 ml oral solution
PA1142/029/003
Levothyroxine sodium Amdipharm Limited Not marketed
Levothyroxine sodium Aristo 100 micrograms tablets
PA1983/004/003
Levothyroxine sodium Aristo Pharma GmbH Marketed
Levothyroxine sodium Aristo 112 microgram tablets
PA1983/004/009
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 125 micrograms tablets
PA1983/004/006
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 137 microgram tablets
PA1983/004/010
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 150 micrograms tablets
PA1983/004/007
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
3 4 5 6 7 8 9

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.